Clinical dosage of meclozine promotes longitudinal bone growth, bone volume, and trabecular bone quality in transgenic mice with achondroplasia

MLA

Masaki Matsushita, et al. “Clinical Dosage of Meclozine Promotes Longitudinal Bone Growth, Bone Volume, and Trabecular Bone Quality in Transgenic Mice with Achondroplasia.” Scientific Reports, vol. 7, no. 1, Aug. 2017, pp. 1–9. EBSCOhost, https://doi.org/10.1038/s41598-017-07044-8.

APA

Masaki Matsushita, Ryusaku Esaki, Kenichi Mishima, Naoki Ishiguro, Kinji Ohno, & Hiroshi Kitoh. (2017). Clinical dosage of meclozine promotes longitudinal bone growth, bone volume, and trabecular bone quality in transgenic mice with achondroplasia. Scientific Reports, 7(1), 1–9. https://doi.org/10.1038/s41598-017-07044-8

Chicago

Masaki Matsushita, Ryusaku Esaki, Kenichi Mishima, Naoki Ishiguro, Kinji Ohno, and Hiroshi Kitoh. 2017. “Clinical Dosage of Meclozine Promotes Longitudinal Bone Growth, Bone Volume, and Trabecular Bone Quality in Transgenic Mice with Achondroplasia.” Scientific Reports 7 (1): 1–9. doi:10.1038/s41598-017-07044-8.